John Stone
Physician · Massachusetts General Hospital
Credentials: · · · · · · ·
History
Research
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism · 2013 · 4,922 citations
Review · New England Journal of Medicine · 2012 · First of 3 authors · Corresponding · 2,085 citations
Rituximab versus cyclophosphamide for ANCA-associated vasculitis
New England Journal of Medicine · 2010 · First of 30 authors · 2,067 citations

84 papers
- ZW
78 papers · 18 as a resident

70 papers

69 papers

59 papers
- GH
56 papers

55 papers

51 papers
Grants
- 2019–2029
Targeting T Cell Subsets in Autoimmune Disease
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $1.4M · Massachusetts General Hospital
- 1999–2012
Resource for Macromolecular Modeling and Bioinformatics
National Center for Research Resources · P41
Project lead · $2.3M · University of Illinois at Urbana-Champaign
- 2011–2012
The First International Symposium on IgG4-Related Systemic Disease
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R13
Contact PI · $22.5K · Massachusetts General Hospital
- 2003–2008
Translational Research in Systemic Vasculitis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K24
Contact PI · $350.9K · Johns Hopkins University
Clinical trials
- 2020
Efficacy of Tocilizumab on Patients With COVID-19
Principal investigator · Completed · Phase 3
Massachusetts General Hospital
- 2018–2020
Safety and Efficacy of Abatacept in IgG4-Related Disease
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
- 2016–2017
Principal investigator · Completed · Phase 2
Xencor, Inc.
- 2014–2017
Principal investigator · Completed · Phase 4
Massachusetts General Hospital


